Common Stock SEC Reporting - Current
Verified Company Profile 6/16/2016
Contact Info
  • 48 Wall Street
  • Suite 1100
  • New York, NY 10005

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001537917
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees Not Available
Company Officers/Contacts
Steven Hoffman CEO
Michael Demurjian COO
Robert Dickey IV VP, Fin., CFO
Company Directors
Michael Demurjian
Steven Hoffman
Gerald Sokol
Tommy Thompson
Timothy Tyson
Service Providers
Accounting/Auditing Firm
Grant Thornton
666 Third Avenue
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
In-Site Communications, Inc.
515 Madison Avenue
Suite 14B
New York, NY, 10022
United States

TYMI Security Details
Share Structure
Market Value1 $319,841,609 a/o Oct 26, 2016
Authorized Shares 300,000,000 a/o Apr 18, 2016
Outstanding Shares 87,627,838 a/o Aug 03, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 10,175,400 a/o Apr 18, 2016
Par Value Not Available
Shareholders of Record 198 a/o Aug 01, 2016
Short Selling Data
Short Interest 7,217 (-25.79%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security